ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995

UNM Gets $1.8 Million For Nanotechnology Center

February 18, 2011

Stand Up To Cancer Awards 13 Grants

January 15, 2010

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013